Table 1.
TFA intake (g/day) |
Relative risk of CHD |
||||||
---|---|---|---|---|---|---|---|
Study name (reference) | No. of subjects | No. of cases | Definition of end points | Industrial | Ruminant | Industrial | Ruminant |
Prospective cohort studies | |||||||
Nurses’ Health Study (13) | 85,095 W | 431 | Non-fatal MI or coronary death | 1.44–3.42 | 0.96–2.28 | 1.78 (p=0.009)* | 0.59 (p=0.23)* |
ATBC Study (14) | 21,930 M | 635 | Coronary death | 0.1–5.1 | 0.6–2.5 | 1.23 (p=0.004)* | 0.83 (p=0.0035)* |
Zutphen Cohort Study (15) | 667 M | 98 | Fatal and non-fatal MI | 5.0 | 1.7 | 1.05 | 1.17 |
Danish ruminant trans fatty acid study (16) | 1,866 M | 253 | Fatal and non-fatal MI | – | 0.6–4.1 | – | 1.00 (0.91–1.07) |
1,911 W | 121 | Fatal and non-fatal MI | – | 0.5–3.1 | – | 0.84 (0.70–1.01) | |
Case-control studies | |||||||
Ascherio et al. (17) | 407 M; 114 W | 239 | MI | 0.84–5.04 | 0.45–1.79 | 1.94 (p=0.0001)* | 1.02 (p=0.57)* |
Adapted from Weggemans et al. (19).
MI = myocardial infarction, CHD = coronary heart disease, W = women. M = men.
*p for trend.